Ozempic vs. Amaryl

See how Ozempic and Amaryl compare on approved uses, dosing, side effects, and cost.

Key Takeaways

  • Ozempic and Amaryl both lower blood sugar in type 2 diabetes, but only Ozempic has FDA approval for cardiovascular and kidney protection in at-risk patients.

  • Ozempic is a once-weekly injection with a higher list price, while Amaryl is a once-daily oral tablet available as a low-cost generic.

  • Amaryl carries a real risk of hypoglycemia, while Ozempic's most common side effects are gastrointestinal, like nausea and vomiting.

Ozempic vs. Amaryl Drug Summary

Ozempic

Ozempic is a GLP-1 receptor agonist that lowers blood sugar in adults with type 2 diabetes. It also reduces the risk of heart attack, stroke, and cardiovascular death in patients with existing heart disease, and slows kidney damage progression. It is given as a once-weekly injection under the skin.

Amaryl

Amaryl is a sulfonylurea that lowers blood sugar in adults with type 2 diabetes by helping the pancreas release more insulin. It is taken as a once-daily oral tablet, alongside diet and exercise. It has been used for decades and is available as a low-cost generic.

Ozempic vs. Amaryl Side Effects

Ozempic

Most common
nausea (up to 20.3%)
vomiting (up to 9.2%)
diarrhea (up to 8.8%)
abdominal pain (up to 7.3%)

Amaryl

Most common
hypoglycemia (up to 19.7%)
accidental injury (up to 16%)
dizziness (up to 5%)
asthenia (up to 5%)

Ozempic vs. Amaryl Dosage

Ozempic

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 0.25 mg once weekly Weeks 1-4
Maximum dose 0.5 mg once weekly Week 5 onward
Dose changes 1 increase Every 4 weeks

Amaryl

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 8 mg once daily At the start
Maximum dose 8 mg once daily Same as starting
Dose changes None Fixed dose

Ozempic vs. Amaryl Indications

Ozempic

Ozempic is FDA-approved to improve blood sugar control in type 2 diabetes when combined with diet and exercise. It also carries specific approvals to reduce major cardiovascular events in patients with known heart disease and to slow chronic kidney disease progression. These added indications make it a common choice for diabetics with cardiovascular or kidney risk factors.

  • Blood sugar control in type 2 diabetes with diet and exercise

  • Reduces risk of heart attack, stroke, and cardiovascular death in patients with heart disease

  • Slows kidney damage progression in chronic kidney disease

  • Not approved for weight loss (that indication belongs to Wegovy)

Amaryl

Amaryl is FDA-approved as an adjunct to diet and exercise to improve blood sugar control in adults with type 2 diabetes. It does not carry approvals for cardiovascular or kidney protection like some newer diabetes drugs. It is often used as a first-line or add-on oral option, including in combination with insulin.

  • Blood sugar control in type 2 diabetes with diet and exercise

  • Can be added to insulin therapy if sulfonylurea alone is not enough

  • Only sulfonylurea FDA-approved for combination therapy with insulin

  • Not approved for cardiovascular or kidney protection

Ozempic vs. Amaryl Pros and Cons

Ozempic

Ozempic offers benefits beyond blood sugar control, including proven cardiovascular and kidney protection in at-risk patients. It requires only one injection per week, but it carries a boxed warning for thyroid tumors seen in animal studies and costs more without insurance.

Pros

  • Reduces cardiovascular risk in patients with heart disease

  • Slows chronic kidney disease progression

  • Once-weekly injection, no daily pills

  • Often causes weight loss as a side benefit

Cons

  • Requires injection, not a pill

  • Common GI side effects like nausea and vomiting

  • Boxed warning for thyroid C-cell tumors

  • Roughly $935 to $1,043 per month without insurance, before savings programs

Amaryl

Amaryl works differently, stimulating the pancreas to release more insulin, and it comes as a once-daily tablet. It has been available for decades as a low-cost generic, but it carries a higher risk of hypoglycemia than newer options like Ozempic. It also lacks any proven cardiovascular or kidney benefit.

Pros

  • Once-daily oral tablet, no injections

  • Roughly $15 to $110 per month without insurance, before savings programs

  • Decades of clinical use and established safety profile

  • Can be combined with insulin for added control

Cons

  • Higher risk of hypoglycemia, especially with missed meals

  • Possible increased cardiovascular mortality risk noted in older studies

  • No proven cardiovascular or kidney protective benefit

  • Requires careful dosing to avoid dizziness or accidental injury

Common Symptoms and Related Diseases You Can Explore

Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.